Leptin and ghrelin: how the body's hunger and fullness hormones work

Two hormones, opposite signals

The body uses a network of hormonal signals to keep track of its energy status and to coordinate the everyday sense of hunger and fullness. Two of the most studied of these signals are leptin and ghrelin, which are often described as opposites. Leptin is understood to act largely as a satiety or 'energy sufficiency' signal, while ghrelin is understood to act as a hunger signal. Together they are part of how the brain registers whether the body has enough stored fuel and whether it is time to eat.

The two hormones also operate on different timescales. Leptin is released in rough proportion to the body's fat stores and is understood to communicate a longer-term picture of how much energy is banked away. Ghrelin, by contrast, tends to fluctuate around individual meals — rising during the gap between eating and easing after food arrives — so it is often framed as a shorter-term, meal-to-meal cue. Both send their information toward appetite-regulating regions of the brain.

This article is educational only and is not medical advice. It describes how these hormones and their receptors are currently understood to work, not what any particular person will experience, and it does not recommend any product or course of action. Any decision about treatment is made by a licensed provider based on an individual's health, not by a general explainer like this one.

How leptin signals energy sufficiency

Leptin is a hormone produced mainly by white adipose tissue — the body's fat cells, or adipocytes. Because more fat tissue generally releases more leptin, the amount circulating in the blood tends to track the body's overall fat mass. For this reason leptin is often described as an 'adiposity signal': a hormonal readout of how much stored energy the body is carrying. It was first identified in the 1990s through study of the gene that encodes it, and it has been a central focus of appetite research ever since.

Leptin is understood to act on leptin receptors concentrated in the hypothalamus, a region at the base of the brain involved in regulating appetite and energy balance. Within a hypothalamic area called the arcuate nucleus, leptin is understood to stimulate one population of neurons associated with reduced appetite while dampening a second population associated with increased appetite. The net effect described in the literature is a signal of energy sufficiency — a message that stores are adequate, which is associated with a lower drive to eat.

Researchers also study a phenomenon often called leptin resistance. In this description, some individuals carry high circulating leptin levels yet appear to show a reduced central response to the hormone, as though the 'stores are sufficient' message is not fully registered by the brain. Leptin resistance is an active and still-evolving area of investigation rather than a settled or simple mechanism, and it is described here only to explain how scientists think about the pathway — not as a diagnosis or a basis for any decision.

How ghrelin signals hunger

Ghrelin is produced chiefly by specialized cells in the lining of the stomach, with smaller amounts arising elsewhere in the gastrointestinal tract. It is the main circulating hormone known to rise in the period before a meal and to fall again after eating, which is why it is frequently called the 'hunger hormone.' In mechanistic terms it is described as orexigenic, meaning its signaling is associated with promoting appetite rather than suppressing it — the mirror image of leptin's role.

Ghrelin is understood to act on a receptor known as the growth hormone secretagogue receptor, or GHSR-1a. That name reflects its history: ghrelin was originally identified through its ability to stimulate the release of growth hormone from the pituitary gland. The same receptor is also present on appetite-related neurons in the hypothalamus, and ghrelin's action there is understood to be part of how the hormone relays a hunger signal to the brain's appetite centers.

One detail scientists emphasize is that ghrelin requires a specific chemical modification to activate its receptor. An enzyme attaches a fatty-acid group to the hormone in a step called acylation, and this acylated form is understood to be the one that engages GHSR-1a. Describing this activation step is part of explaining how the pathway is thought to work at a molecular level; it is background biology, not guidance about any medication or intervention.

Where the signals meet: the brain's appetite centers

Leptin and ghrelin do not act in isolation — they converge on shared circuitry in the brain. The arcuate nucleus of the hypothalamus is often described as a key integration hub, home to two opposing populations of neurons. One population is associated with promoting hunger, and the other with promoting fullness. Leptin and ghrelin are understood to push these two populations in opposite directions, which is one reason the hormones are so frequently discussed as a pair.

Downstream of these neurons sits a signaling system often called the melanocortin pathway. Neurons associated with fullness release a messenger that acts on a receptor known as MC4R, and this branch of the circuit is understood to be an important relay in how the brain translates hormonal input into the perception of appetite. When researchers describe leptin as anorexigenic and ghrelin as orexigenic, they are in part describing how each hormone tips the balance within this shared network.

Appetite regulation, though, involves far more than these two hormones. The same brain centers also integrate signals from insulin, from gut hormones such as GLP-1, PYY, and CCK, and from nerve pathways like the vagus nerve that carry information from the digestive tract. The overall picture is one of a distributed network with many inputs rather than a single on-off switch, and scientists continue to study how the pieces interact. This guide summarizes that understanding at a high level; it does not capture every detail or predict any individual's experience.

How this connects to other appetite pathways

Leptin and ghrelin are the body's own hormones — signals it produces internally to manage energy balance. Because they feed into the same appetite centers as gut hormones like GLP-1 and the other incretins, these systems are often discussed together when explaining how the body registers hunger and fullness. Some prescription medications are studied for how they engage these overlapping gut-brain pathways, which is why the biology of the body's natural hunger and satiety hormones is a common starting point for that discussion.

It is important to separate describing a shared pathway from making any claim about a medication's effect. Explaining that several signals converge on the same appetite circuitry is a statement about mechanism, not about outcomes for any person. Whether a given medication is appropriate for someone is a clinical judgment made by an independent licensed provider who weighs that individual's full health picture. Compounded medications, where relevant, are not FDA-approved products, and statements about them have not been evaluated by the FDA.

Educational scope and how review works on OpenDoseRx

This article is intended to explain mechanism — how leptin, ghrelin, and their receptors are understood to signal energy status to the brain. It is educational only, it is not medical advice, and it does not provide dosing, schedules, or recommendations. Nothing here is a substitute for a conversation with your own healthcare provider, and every clinical decision belongs to a licensed provider rather than to a shopper or an article.

On OpenDoseRx, that principle is built into the process. You begin by choosing a product and strength, then complete a medical intake that gathers your health history and other relevant information. The intake is routed to an independent, licensed U.S. provider who reviews it and decides whether a prescription is appropriate for you. If it is, a licensed U.S. pharmacy prepares and ships it; if the request is declined, you are not charged for the medication and receive a full refund. Every product is prescription-only and is dispensed only after this independent clinical review.